IL6 and metabolic dysfunction-associated steatotic liver disease: Circulating concentrations of inflammation markers, such as IL-4, IL-6, C-reactive protein (CRP) and tumour necrosis factor-α receptor 2 (TNFα-R2), have been shown to be associated with NAFLD in prior studies(1,4,5).